New study implicates disease-driving B cells in fatty liver disease development
AstraZeneca hails US trials as EU rows with UK over supplies
22 March 2021Ask the Pediatrician: Are infrared thermometers safe to use on children?
22 March 2021New study implicates disease-driving B cells in fatty liver disease development
New research from the University of Minnesota Medical School suggests that disease-driving B cells, a white blood cell, play a role in the development of non-alcoholic fatty liver disease (NAFLD)—the most common chronic liver condition in the U.S. Their findings could lead to targeted therapies for NAFLD, which currently affects a quarter of the nation and has no FDA-approved treatments.
